Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY 4.0Frontiers in Endocrinology

D-allulose as a candidate modulator of nutrient-responsive signaling: the Metabo Quit hypothesis for healthy aging

  1. 1Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University
  2. 2International Institute of Rare Sugar Research and Education, Kagawa University

Abstract

Deregulated nutrient sensing is a hallmark of aging, but endocrine and anabolic signals remain essential for glucose homeostasis, tissue repair, and preservation of muscle and bone. We propose Metabo Quit as a testable dietary framework for reducing persistent nutrient-responsive growth signaling when it exceeds physiological need, without inducing endocrine deficiency or chronic catabolism. Insulin and insulin-like growth factor 1 (IGF-1) are treated as representative sentinel signals within a wider network that includes amino-acid sensing, mTOR-S6K, PKA, AMPK, FOXO, incretin, and autophagy pathways. D-allulose is positioned as a candidate nutritional probe because controlled human studies support modest attenuation of postprandial glycemia and, in some settings, insulin responses. Importantly, D-allulose extended lifespan in Caenorhabditis elegans under monoxenic and axenic culture conditions; non-additivity in the dietary-restriction model eat-2 and loss of the effect in aak-2 mutants support an aak-2 -dependent, dietary-restriction-like mechanism. This organism-level finding strengthens biological plausibility, but evidence that D-allulose slows biological aging or extends healthspan in mammals or humans is not available. The framework is conceptually aligned with fasting and fasting-mimicking diets while addressing a distinct question: whether an ordinary food substitution can reduce repeated metabolic stimulation without reproducing fasting. We outline matched-meal studies, mechanistic readouts, safety safeguards, and falsification criteria. This Perspective reframes D-allulose beyond sweetening as a tool for testing whether the temporal burden of nutrient-responsive signaling can be moderated in support of healthy aging.

Related

  1. A SynNotch-PiggyBac gene circuit for inflammation-responsive IL-10 delivery in Alzheimer’s disease: a hypothesis and design framework
    Suhani Gupta, Ronav Gupta
    Frontiers in aging neurosciencePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. The Reindeer's Secret: Salazinic Acid from Lichens as a Candidate Modulator of Autophagy.
    Anastasiia K Veretina, Vera A Alferova, Ekaterina A Guseva +15
    International journal of molecular sciencesPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  3. Integrative transcriptomic and computational analysis associates Ms4a6c+ macrophages with fibrosis in radiation proctitis and computationally nominates MOTS-c as a candidate modulator
    Peng Wang, Wei Tao, Hong Wen +6
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyCrossrefEurope PMCPMC
  4. Nutrient-responsive midgut turnover is spatially controlled by serotonin signaling
    N. Lamichane, P. Borgman, T. Rintakangas +11
    bioRxivPreprintCC BYFull textPhysiologybioRxiv
  5. mTORC1-dependent control of Hedgehog signaling mediates nutrient-responsive licensing of intestinal stem cell differentiation
    G. Fabris, S. Biaudet, A. Hallasaari +6
    bioRxivPreprintCC BYFull textPhysiologybioRxiv
BibTeX
@article{fukunaga2026dallulose,
  title = {{D-allulose as a candidate modulator of nutrient-responsive signaling: the Metabo Quit hypothesis for healthy aging}},
  author = {Kensaku Fukunaga and Toshihiro Kobayashi and Takanobu Saheki and Takafumi Yoshimura and Rathana Ly and Hitomi Imachi and Kazuya Akimitsu and Koji Murao},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  month = nov,
  doi = {10.3389/fendo.2026.2009189},
  url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.2009189/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - D-allulose as a candidate modulator of nutrient-responsive signaling: the Metabo Quit hypothesis for healthy aging
AU  - Kensaku Fukunaga
AU  - Toshihiro Kobayashi
AU  - Takanobu Saheki
AU  - Takafumi Yoshimura
AU  - Rathana Ly
AU  - Hitomi Imachi
AU  - Kazuya Akimitsu
AU  - Koji Murao
PY  - 2026
DA  - 2026/11/16
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.2009189
UR  - https://www.frontiersin.org/articles/10.3389/fendo.2026.2009189/full
AB  - Deregulated nutrient sensing is a hallmark of aging, but endocrine and anabolic signals remain essential for glucose homeostasis, tissue repair, and preservation of muscle and bone. We propose Metabo Quit as a testable dietary framework for reducing persistent nutrient-responsive growth signaling when it exceeds physiological need, without inducing endocrine deficiency or chronic catabolism. Insulin and insulin-like growth factor 1 (IGF-1) are treated as representative sentinel signals within a wider network that includes amino-acid sensing, mTOR-S6K, PKA, AMPK, FOXO, incretin, and autophagy pathways. D-allulose is positioned as a candidate nutritional probe because controlled human studies support modest attenuation of postprandial glycemia and, in some settings, insulin responses. Importantly, D-allulose extended lifespan in Caenorhabditis elegans under monoxenic and axenic culture conditions; non-additivity in the dietary-restriction model eat-2 and loss of the effect in aak-2 mutants support an aak-2 -dependent, dietary-restriction-like mechanism. This organism-level finding strengthens biological plausibility, but evidence that D-allulose slows biological aging or extends healthspan in mammals or humans is not available. The framework is conceptually aligned with fasting and fasting-mimicking diets while addressing a distinct question: whether an ordinary food substitution can reduce repeated metabolic stimulation without reproducing fasting. We outline matched-meal studies, mechanistic readouts, safety safeguards, and falsification criteria. This Perspective reframes D-allulose beyond sweetening as a tool for testing whether the temporal burden of nutrient-responsive signaling can be moderated in support of healthy aging.
SN  - 1664-2392
ER  -